HEATHER MAMBRETTI: Open Payments
NPI 1417243726 · LEAGUE CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$64,068 in 260 payments from 23 companies in 2025. Trend: 2023 $15,941 · 2024 $52,083 · 2025 $64,068
Speaker / faculty: $32,269Consulting: $16,004Travel & lodging: $8,470Food & beverage: $7,294Education: $31
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 37 | $20,593 |
| AstraZeneca Pharmaceuticals LP | 31 | $13,752 |
| GENZYME CORPORATION | 15 | $7,595 |
| Janssen Scientific Affairs, LLC | 11 | $6,469 |
| UCB, Inc. | 24 | $5,699 |
| Amgen Inc. | 28 | $3,247 |
| Novartis Pharmaceuticals Corporation | 15 | $2,047 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $1,280 |
| Mallinckrodt Hospital Products Inc. | 12 | $1,262 |
| ABBVIE INC. | 30 | $808 |
Products named: TREMFYA, SAPHNELO, KEVZARA, Bimzelx, BLINCYTO, ACTHAR, RINVOQ, SKYRIZI.
Industry payments across TX — which companies pay providers there.
